Global Neurological Biomarkers Competitive Landscape Professional Research Report 2025
Description
Global Neurological Biomarkers Competitive Landscape Professional Research Report 2025
Research Summary
Neurological biomarkers are measurable indicators or characteristics that provide information about the state or function of the nervous system. These biomarkers can include various physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities or patterns observed in brain imaging scans (such as magnetic resonance imaging or positron emission tomography), and electrical activity recorded from the brain (such as electroencephalography). Neurological biomarkers can help in the diagnosis, prognosis, and monitoring of neurological disorders, as well as in the development and evaluation of new treatments and interventions. They serve as objective measures that complement clinical assessments, aiding in the understanding of disease progression, response to therapy, and the identification of potential therapeutic targets.
According to DIResearch's in-depth investigation and research, the global Neurological Biomarkers market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Neurological Biomarkers include Thermo Fisher Scientific, Merck, Quest Diagnostics, Roche, Abbott, QIAGEN, Bio-Rad Laboratories, Illumina, Cisbio Bioassays, Myriad RBM, Athena Diagnostics, BGI, Wuxi APP, Aepodia, Proteome Sciences, Genewiz etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neurological Biomarkers. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Neurological Biomarkers market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Neurological Biomarkers market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurological Biomarkers industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Neurological Biomarkers Include:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Roche
Abbott
QIAGEN
Bio-Rad Laboratories
Illumina
Cisbio Bioassays
Myriad RBM
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
Neurological Biomarkers Product Segment Include:
Proteomics
Genomics
Imaging
Bioinformatics
Others
Neurological Biomarkers Product Application Include:
Diagnostics
Drug Discovery
Personalized Medicine
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Neurological Biomarkers Industry PESTEL Analysis
Chapter 3: Global Neurological Biomarkers Industry Porter’s Five Forces Analysis
Chapter 4: Global Neurological Biomarkers Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Neurological Biomarkers Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Neurological Biomarkers Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Neurological Biomarkers Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Neurological Biomarkers Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Neurological Biomarkers Product by Type
- 1.2.1 Proteomics
- 1.2.2 Genomics
- 1.2.3 Imaging
- 1.2.4 Bioinformatics
- 1.2.5 Others
- 1.3 Neurological Biomarkers Product by Application
- 1.3.1 Diagnostics
- 1.3.2 Drug Discovery
- 1.3.3 Personalized Medicine
- 1.3.4 Others
- 1.4 Global Neurological Biomarkers Market Revenue and Sales Analysis
- 1.4.1 Global Neurological Biomarkers Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Neurological Biomarkers Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Neurological Biomarkers Market Sales Price Trend Analysis (2020-2032)
- 1.5 Neurological Biomarkers Industry Trends and Innovation
- 1.5.1 Neurological Biomarkers Industry Trends and Innovation
- 1.5.2 Neurological Biomarkers Market Drivers and Challenges
- 2 Neurological Biomarkers Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Neurological Biomarkers Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Neurological Biomarkers Market Analysis by Regions
- 4.1 Neurological Biomarkers Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Neurological Biomarkers Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Neurological Biomarkers Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Neurological Biomarkers Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Neurological Biomarkers Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Neurological Biomarkers Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Neurological Biomarkers Sales Forecast by Region (2026-2032)
- 4.4 Global Neurological Biomarkers Sales Price Trend Analysis (2020-2032)
- 5 Global Neurological Biomarkers Market Size by Type and Application
- 5.1 Global Neurological Biomarkers Market Size by Type
- 5.1.1 Global Neurological Biomarkers Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Neurological Biomarkers Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Neurological Biomarkers Market Size by Application
- 5.2.1 Global Neurological Biomarkers Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Neurological Biomarkers Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Neurological Biomarkers Market Size by Type
- 6.3.1 North America Neurological Biomarkers Sales by Type (2020-2032)
- 6.3.2 North America Neurological Biomarkers Revenue by Type (2020-2032)
- 6.4 North America Neurological Biomarkers Market Size by Application
- 6.4.1 North America Neurological Biomarkers Sales by Application (2020-2032)
- 6.4.2 North America Neurological Biomarkers Revenue by Application (2020-2032)
- 6.5 North America Neurological Biomarkers Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Neurological Biomarkers Market Size by Type
- 7.3.1 Europe Neurological Biomarkers Sales by Type (2020-2032)
- 7.3.2 Europe Neurological Biomarkers Revenue by Type (2020-2032)
- 7.4 Europe Neurological Biomarkers Market Size by Application
- 7.4.1 Europe Neurological Biomarkers Sales by Application (2020-2032)
- 7.4.2 Europe Neurological Biomarkers Revenue by Application (2020-2032)
- 7.5 Europe Neurological Biomarkers Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Neurological Biomarkers Market Size by Type
- 8.3.1 China Neurological Biomarkers Sales by Type (2020-2032)
- 8.3.2 China Neurological Biomarkers Revenue by Type (2020-2032)
- 8.4 China Neurological Biomarkers Market Size by Application
- 8.4.1 China Neurological Biomarkers Sales by Application (2020-2032)
- 8.4.2 China Neurological Biomarkers Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Neurological Biomarkers Market Size by Type
- 9.3.1 APAC (excl. China) Neurological Biomarkers Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Neurological Biomarkers Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Neurological Biomarkers Market Size by Application
- 9.4.1 APAC (excl. China) Neurological Biomarkers Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Neurological Biomarkers Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Neurological Biomarkers Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Neurological Biomarkers Market Size by Type
- 10.3.1 Latin America Neurological Biomarkers Sales by Type (2020-2032)
- 10.3.2 Latin America Neurological Biomarkers Revenue by Type (2020-2032)
- 10.4 Latin America Neurological Biomarkers Market Size by Application
- 10.4.1 Latin America Neurological Biomarkers Sales by Application (2020-2032)
- 10.4.2 Latin America Neurological Biomarkers Revenue by Application (2020-2032)
- 10.5 Latin America Neurological Biomarkers Market Size by Country
- 10.6 Latin America Neurological Biomarkers Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Neurological Biomarkers Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Neurological Biomarkers Market Size by Type
- 11.3.1 Middle East & Africa Neurological Biomarkers Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Neurological Biomarkers Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Neurological Biomarkers Market Size by Application
- 11.4.1 Middle East & Africa Neurological Biomarkers Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Neurological Biomarkers Revenue by Application (2020-2032)
- 11.5 Middle East Neurological Biomarkers Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Neurological Biomarkers Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Neurological Biomarkers Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Neurological Biomarkers Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Neurological Biomarkers Average Sales Price by Manufacturers (2021-2025)
- 12.2 Neurological Biomarkers Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Neurological Biomarkers Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Thermo Fisher Scientific
- 13.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Portfolio
- 13.1.3 Thermo Fisher Scientific Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Merck
- 13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Merck Neurological Biomarkers Product Portfolio
- 13.2.3 Merck Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Quest Diagnostics
- 13.3.1 Quest Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Quest Diagnostics Neurological Biomarkers Product Portfolio
- 13.3.3 Quest Diagnostics Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Roche
- 13.4.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Roche Neurological Biomarkers Product Portfolio
- 13.4.3 Roche Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Abbott
- 13.5.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Abbott Neurological Biomarkers Product Portfolio
- 13.5.3 Abbott Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 QIAGEN
- 13.6.1 QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 QIAGEN Neurological Biomarkers Product Portfolio
- 13.6.3 QIAGEN Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Bio-Rad Laboratories
- 13.7.1 Bio-Rad Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Portfolio
- 13.7.3 Bio-Rad Laboratories Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Illumina
- 13.8.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Illumina Neurological Biomarkers Product Portfolio
- 13.8.3 Illumina Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Cisbio Bioassays
- 13.9.1 Cisbio Bioassays Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Cisbio Bioassays Neurological Biomarkers Product Portfolio
- 13.9.3 Cisbio Bioassays Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Myriad RBM
- 13.10.1 Myriad RBM Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Myriad RBM Neurological Biomarkers Product Portfolio
- 13.10.3 Myriad RBM Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 Athena Diagnostics
- 13.11.1 Athena Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Athena Diagnostics Neurological Biomarkers Product Portfolio
- 13.11.3 Athena Diagnostics Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 BGI
- 13.12.1 BGI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 BGI Neurological Biomarkers Product Portfolio
- 13.12.3 BGI Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Wuxi APP
- 13.13.1 Wuxi APP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Wuxi APP Neurological Biomarkers Product Portfolio
- 13.13.3 Wuxi APP Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Aepodia
- 13.14.1 Aepodia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Aepodia Neurological Biomarkers Product Portfolio
- 13.14.3 Aepodia Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.15 Proteome Sciences
- 13.15.1 Proteome Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Proteome Sciences Neurological Biomarkers Product Portfolio
- 13.15.3 Proteome Sciences Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.16 Genewiz
- 13.16.1 Genewiz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Genewiz Neurological Biomarkers Product Portfolio
- 13.16.3 Genewiz Neurological Biomarkers Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Neurological Biomarkers Industry Chain Analysis
- 14.2 Neurological Biomarkers Industry Raw Material and Suppliers Analysis
- 14.2.1 Neurological Biomarkers Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Neurological Biomarkers Typical Downstream Customers
- 14.4 Neurological Biomarkers Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
